Literature DB >> 19895591

Molecular variability of group 1 and 5 grass pollen allergens between Pooideae species: implications for immunotherapy.

H Chabre1, B Gouyon, A Huet, V Baron-Bodo, V Boran-Bodo, E Nony, M Hrabina, F Fenaille, A Lautrette, M Bonvalet, B Maillère, V Bordas-Le Floch, L Van Overtvelt, K Jain, E Ezan, T Batard, P Moingeon.   

Abstract

BACKGROUND: Differences between major allergens from distinct grass species remain to be investigated, both in terms of structure and antigenicity.
METHODS: Group 1 and 5 allergens purified from five common Pooideae species were analysed by mass spectrometry (MS). Major histocompatibility complex (MHC) class II-restricted T cell epitopes were identified using predictive algorithms and human leucocyte antigen (HLA)-binding assays. CD4+ T cell reactivity and IgE binding were assessed based on the induction of CD154 expression in peripheral blood mononuclear cells and using competitive ELISA assays, respectively.
RESULTS: MS analysis of group 5 pollen allergens reveals considerable intra- and inter-species variability in amino acid sequence, with 30-50 predominant isoforms found for each species. Differences in the amino acid sequence as well as N- and O-glycosylation contribute to the variability of group 1 allergens, yielding 5-10 main isoforms, depending on the species. Out of 14 MHC class II-restricted T cell epitopes identified within group 1, only one is conserved among the five grass species. Significant differences in binding affinities for HLA-DR molecules result in variable CD4+ T cell recognition of group 1 and 5 allergens purified from the various species. Up to 38% and 85% of patients exhibit seric IgE responses to species-restricted (or semi-restricted) epitopes associated with group 1 or 5 allergens, respectively.
CONCLUSION: Major pollen allergens from distinct grass species bear both shared and species-restricted T and B cell immune epitopes. When compared with single extracts, a five grass pollen extract is thus more suitable for specific immunotherapy, as it contains a broader repertoire of the IgE epitopes to which patients are sensitized.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19895591     DOI: 10.1111/j.1365-2222.2009.03380.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  14 in total

Review 1.  Bacterial expansins and related proteins from the world of microbes.

Authors:  Nikolaos Georgelis; Nikolas Nikolaidis; Daniel J Cosgrove
Journal:  Appl Microbiol Biotechnol       Date:  2015-04-02       Impact factor: 4.813

2.  A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma.

Authors:  Wenting Luo; Guichang Pan; Huimin Huang; Peiyan Zheng; Nili Wei; Yifei Zhang; Guangqiao Zeng; Baoqing Sun
Journal:  J Vis Exp       Date:  2017-06-04       Impact factor: 1.355

3.  Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.

Authors:  M Levin; S Rotthus; S Wendel; N Najafi; E Källström; M Focke-Tejkl; R Valenta; S Flicker; M Ohlin
Journal:  Clin Exp Allergy       Date:  2014-11       Impact factor: 5.018

4.  Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy.

Authors:  L D Archila; J H DeLong; E Wambre; E A James; D M Robinson; W W Kwok
Journal:  Clin Exp Allergy       Date:  2014-07       Impact factor: 5.018

5.  Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation.

Authors:  Stephen J Till; Eleanor J Raynsford; Catherine J Reynolds; Kathryn J Quigley; Agnieszka Grzybowska-Kowalczyk; Lavina R Saggar; Andrea Goldstone; Bernard Maillere; William W Kwok; Daniel M Altmann; Stephen R Durham; Rosemary J Boyton
Journal:  Thorax       Date:  2013-11-20       Impact factor: 9.139

6.  Subtropical grass pollen allergens are important for allergic respiratory diseases in subtropical regions.

Authors:  Janet Mary Davies; Hongzhuo Li; Melissa Green; Michelle Towers; John Warrick Upham
Journal:  Clin Transl Allergy       Date:  2012-03-05       Impact factor: 5.871

7.  A major step forward for sublingual immunotherapy: the quality of 5-grass pollen tablet is recognized also in Italy.

Authors:  Giorgio Ciprandi
Journal:  J Asthma Allergy       Date:  2015-03-06

8.  Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain.

Authors:  Darío Antolín-Amerigo; Isabel A Tabar; Maria Del Mar Fernández-Nieto; Anna M Callejo-Melgosa; Francisco J Muñoz-Bellido; José C Martínez-Alonso; Jorge D Méndez-Alcalde; Marta Reche; Ana Rodríguez-Trabado; Ana Rosado-Ingelmo; Alicia Alonso-Gómez; Rosa Blanco-González; José A Alvarez-Fernandez; Isabel Botella; Ana Valls; Mercedes Cimarra; Carlos Blanco
Journal:  Drugs Context       Date:  2017-11-29

Review 9.  Multiple grass mixes as opposed to single grasses for allergen immunotherapy in allergic rhinitis.

Authors:  K Gangl; V Niederberger; R Valenta
Journal:  Clin Exp Allergy       Date:  2013-11       Impact factor: 5.018

10.  A proteomic style approach to characterize a grass mix product reveals potential immunotherapeutic benefit.

Authors:  Alan Bullimore; Nicola Swan; Wemimo Alawode; Murray Skinner
Journal:  World Allergy Organ J       Date:  2011-09-03       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.